Replies to post #86222 on Innovation Pharmaceuticals Inc (IPIX)

[John B]

They would most likely qualify to Nasdaq under:
Nasdaq Capital Market (Market Value of Listed Securities Standard*)
This is on Page 9 on the document here:
https://listingcenter.nasdaqomx.com/assets/initialguide.pdf

They need to keep the Share Price above $4 for 90 consecutive trading days OR they need to boost net tangible assets to $5 million. Either one can be done.

[TOB]

That's not correct, there are other standards for NASDAQ that do not require income. Plus, income is not only sales, income from a partnership could meet the income standards.

Again, they don't meet the current standards to up-list. Are they all-of-a sudden going to have sales this year? Leo needs to read the rules!!!-Rdunn88

Here are the actual rules. In NASDAQ Global Market: Income is only for the Income Standard. CTIX would meet the Market Value Standard.

Under NASDAQ Capital Market: The Equity Standard and Market Value Standard don't include income.

https://listingcenter.nasdaqomx.com/assets/initialguide.pdf

What CTIX does need are minimum Bid or closing price requirements, and to meet additional corporate governance standards.

CTIX Up-list to the NASDAQ looks like it's in the bag for 2015.

[sox040713]

There are at least 10 biotechs on my watch list which do not have sales but are on NASDAQ. One of them has a market cap of $48M.

Again, they don't meet the current standards to up-list.

[bramkers]

Is this all true?
How is for example NWBO listed on NASDAQ?
No income, do they?
How does Leo say that he has the "Nasdaq application filled out on his desk", without any sales in the foreseeable future?
What am I missing?